The AERIAL trial will assess LEU011, which has MHRA Innovation Passport status, for solid tumors, a challenging area compared ...

A small papillary thyroid cancer study demonstrates favorable outcomes and highlights the role of American Thyroid ...

During a live event, Shannon N. Westin, MD, MPH, and participants discussed their experience treating patients with ...

A panelist discusses how managing adverse events (AEs) in patients with chronic graft-vs-host disease (cGVHD) treated with ruxolitinib requires a structured monitoring approach that balances ...